Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Events Preview: KC Design Week, Lean Lab Innovation Workshop
There are a plethora of entrepreneurial events hosted in Kansas City on a weekly basis. Whether you’re an entrepreneur, investor, supporter, or curious community member — we recommend these upcoming events for you. Are you hosting a relevant community event? Feel free to add it to the FWD/KC calendar for increased exposure. Once your event…
Yoga for five-year-olds? Visionary KC charter school launching pilot program
Kansas City-based elementary school Dreams KC will launch its first pilot program this month, but don’t expect the same old classroom model “Dreams is a whole child model,” explained Catina Taylor, founder of Dreams KC. “What that means is we don’t focus on them from the neck up, we develop their civic, personal, professional and…
Gooding: Your customers don’t care about you
Editor’s note: The opinions expressed in this commentary are the author’s alone. Check out more from Grant Gooding here. It’s true. The moment you start talking about yourself is the moment you start losing. There is no doubt that as human beings we have a natural affinity to talk about ourselves; self-promotion is hard-wired…
KU Health System pilots KC health startup in rural Kansas
Kansas City-based software startup Redivus Health landed a partnership with the University of Kansas Health system, which will put its technology in the hands of many rural Kansans. Launched in 2012, Redivus Health was founded by a group of physicians wanting to create better solutions for critical care situations. In 2015, the firm created a…